Preliminary results to be presented at IARS 2017

Uppsala, March 13, 2017. Senzime AB (publ) is happy to announce that the abstract authored by Dr. J. Ross Renew from the Mayo Clinic and entitled, “Examining Awake Volunteer Pain Scores and Operator Ease of Use of a Novel Neuromuscular Blockade Monitor” was accepted for publication. The volunteer study compared the TetraGraph and TOF-Watch, and the results will be presented at IARS (International Anesthesia Research Society) 2017 Annual Meeting and International Science Symposium, in Washington DC, May 6-9.

Senzime AB (publ) launches new website

Senzime in the news- Needle-free probe provides information on how organs and tissues recover after surgery

Uppsala BIO and BIO-X writes about Senzime in their news. Senzime has developed an integrated monitoring system that can provide information on the state of a body’s organs. A probe (OnZurf Probe) placed on the tissue surface collects a microdialysis sample that is read by an instrument (CliniSenz Analyzer). Senzime is one of the companies that received funding in the BIO-X call ‘New diagnostic solutions for disease monitoring’.

Senzime introduces TetraGraph film

Uppsala, October 28, 2016. Senzime proudly presents a new film describing TetraGraph

Meet Senzime at Medica Trade Fair in Düsseldorf, 14-17 November

Senzime introduces new graphical profile

Uppsala, October 3, 2016. Senzime AB (publ.) changes graphic profile. Following the acquisition and integration of Acacia Designs BV, a new graphical profile is introduced to reflect the new Senzime - a company at the forefront of patient monitoring.

Senzime introduces new graphical profile

Uppsala, October 3, 2016. Senzime AB (publ.) changes graphic profile. Following the acquisition and integration of Acacia Designs BV, a new graphical profile is introduced to reflect the new Senzime - a company at the forefront of patient monitoring.

Preclinical results from OnZurf probe will be presented at clinical congresses

Uppsala, August 19, 2016. Results from preclinical studies with OnZurf probe will be presented at “Kirurgveckan” in Malmö/Lund and at “The International Society for Diseases of the Esophagus” in Singapore.

We are launching our new website!

Monitoring of ischemia with OnZurf Probe is accepted for scientific publication